Industry News
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to patients with liver disease — poses a low risk for causing antibiotic resistance. [ + ]
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating baby corals in laboratories, offering a groundbreaking new approach to coral restoration efforts. [ + ]
Evident names 5th Annual Image of the Year Award winners
View the six winning entries in Evident's 5th Annual Image of the Year Award — a competition that recognises the world's best in scientific microscopic imaging. [ + ]
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up the development of new medical therapies on Earth — following experiments conducted on a private space mission. [ + ]
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight cancer, after reintroduction into the body of a cancer patient. [ + ]
'Phantom chemical' in drinking water finally identified
Researchers have discovered a previously unknown compound in chloraminated drinking water — a compound whose existence, if not its identity, has been known for 30 years. [ + ]
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping ability. There is also a risk that these patients will become depressed by the treatment. [ + ]
Nanoplastics can reduce effectiveness of antibiotics
Using complex computer models, researchers were able to prove that nanoplastic particles can bind the antibiotic known as tetracycline and thus impair its effectiveness. [ + ]
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing female scientists from ANZ, while ATSE has announced 250+ scholarships as part of its Elevate: Boosting diversity in STEM program. [ + ]
FDA approves new treatment for graft-versus-host disease
Back in 2014, Dr Kelli MacDonald's lab at QIMR Berghofer identified the cellular process causing chronic GVHD as well as the antibody that could block this process. [ + ]
CRISPR molecular scissors can introduce genetic defects
CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases, but they can also lead to new defects when it comes to chronic granulomatous disease. [ + ]
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in neurodegenerative disease, particularly MND and frontotemporal dementia. [ + ]
High-potency cannabis use leaves a unique mark on DNA
Frequent users of high-potency cannabis have changes in genes related to mitochondrial and immune function — particularly the CAVIN1 gene, which could affect energy and immune response. [ + ]
Flinders facility to use the micro realm to understand the past
AusMAP aims to revolutionise the ways scientists address key questions and grand challenges in the fields of archaeology, palaeontology and the geosciences. [ + ]
Scaffold-based method for culturing antitumour bacteria
Bacteria-based cancer therapy represents an exciting new treatment option — but in order to fully harness this approach, a safe and efficient method for producing natural anticancer bacteria is needed. [ + ]
